G.N. Woodruff

9.5k total citations · 1 hit paper
151 papers, 8.0k citations indexed

About

G.N. Woodruff is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, G.N. Woodruff has authored 151 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Cellular and Molecular Neuroscience, 78 papers in Molecular Biology and 20 papers in Physiology. Recurrent topics in G.N. Woodruff's work include Neuroscience and Neuropharmacology Research (55 papers), Receptor Mechanisms and Signaling (52 papers) and Neuropeptides and Animal Physiology (46 papers). G.N. Woodruff is often cited by papers focused on Neuroscience and Neuropharmacology Research (55 papers), Receptor Mechanisms and Signaling (52 papers) and Neuropeptides and Animal Physiology (46 papers). G.N. Woodruff collaborates with scholars based in United Kingdom, United States and Japan. G.N. Woodruff's co-authors include Tony Priestley, L L Iversen, J A Kemp, Erik H.F. Wong, A.R. Knight, Joel W. Hughes, R. Gill, Alan C. Foster, John A. Kemp and R.J. Walker and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Physiology.

In The Last Decade

G.N. Woodruff

148 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist.

1986 1.5k citations G.N. Woodruff et al. profile →

Peers

Countries citing papers authored by G.N. Woodruff

Since Specialization

Citations

This map shows the geographic impact of G.N. Woodruff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.N. Woodruff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.N. Woodruff more than expected).

Fields of papers citing papers by G.N. Woodruff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.N. Woodruff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.N. Woodruff. The network helps show where G.N. Woodruff may publish in the future.

Co-authorship network of co-authors of G.N. Woodruff

This figure shows the co-authorship network connecting the top 25 collaborators of G.N. Woodruff. A scholar is included among the top collaborators of G.N. Woodruff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.N. Woodruff. G.N. Woodruff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Concurrent chronic administration of a CCKB antagonist can decrease tolerance to the ataxic effects of ethanol 1999 ·Addiction Biology ·(unknown), G.N. Woodruff, H.J. Little	2
2	Characterization of novel peptoid agonists for the CCK-A receptor 1996 ·Regulatory Peptides ·Joel W. Hughes, G.J. Dockray, David R. Hill, Luis García, Martyn C. Pritchard, Eckart Förster, Emil C. Toescu, G.N. Woodruff, David C. Horwell	13
3	The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed byd-serine 1996 ·Psychopharmacology ·L. Singh, Mark J. Field, (unknown), John C. Hunter, Ryszard J. Oles, Richard G. Williams, G.N. Woodruff	204
4	Differential modulation of κ and μ opioid antinociception by the glycine/NMDA receptor agonist D‐serine 1994 ·British Journal of Pharmacology ·John C. Hunter, Paldeep S. Atwal, G.N. Woodruff, L. Singh	13
5	Species variants of tachykinin receptor types 1994 ·Biochemical Society Transactions ·Keith J. Watling, Steven Guard, (unknown), A.T. McKnight, G.N. Woodruff	12
6	Evaluation of a series of novel CCK_B antagonists using a functional assay in the rat central nervous system 1994 ·British Journal of Pharmacology ·P. Boden, R.D. Pinnock, Martyn C. Pritchard, G.N. Woodruff	6
7	Benzodiazepine/cholecystokinin interactions at functional CCK receptors in rat brain 1994 ·British Journal of Pharmacology ·P. Boden, G.N. Woodruff	4
8	Rational design of high affinity tachykinin NK2 receptor antagonists 1994 ·Bioorganic & Medicinal Chemistry ·(unknown), Steven Guard, (unknown), David C. Horwell, William Howson, Joel W. Hughes, A.T. McKnight, K. Martin, Martyn C. Pritchard, Keith J. Watling, G.N. Woodruff	19
9	The interaction of the NK₁ receptor antagonist CP‐96,345 with L‐type calcium channels and its functional consequences 1993 ·British Journal of Pharmacology ·Steven Guard, (unknown), (unknown), Keith J. Watling, A.T. McKnight, G.N. Woodruff	62
10	Reduction of [125I]Bolton Hunter CCK8 and [3H]MK-329 (devazepide) binding to CCK receptors in the substantia nigra/VTA complex and its forebrain projection areas following MPTP-induced hemi-parkinsonism in the monkey 1991 ·Neuroscience Letters ·W.C. Graham, David R. Hill, G.N. Woodruff, M.A. Sambrook, Alan R. Crossman	17
11	Rationally designed "dipeptoid" analogs of CCK. .alpha.-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic properties 1991 ·Journal of Medicinal Chemistry ·David C. Horwell, Jonathan Hughes, JC Hunter, Martyn C. Pritchard, Russell S. Richardson, Edward Roberts, G.N. Woodruff	142
12	The neuroprotective actions of kynurenic acid and MK-801 in gerbils are synergistic and not related to hypothermia 1990 ·European Journal of Pharmacology ·R. Gill, G.N. Woodruff	83
13	7‐クロルキヌレン酸はN‐メチル‐D‐アスパラギン酸受容体複合体のグリシン調節部位での選択的きっ抗物質である 1988 ·Proc Natl Acad Sci USA ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), G.N. Woodruff	114
14	CCK-A receptors in the rat interpeduncular nucleus: evidence for a presynaptic location 1988 ·Brain Research ·David R. Hill, (unknown), Colin T. Dourish, G.N. Woodruff	22
15	Species differences in the localization of ‘peripheral’ type cholecystokinin receptors in rodent brain 1987 ·Neuroscience Letters ·David R. Hill, (unknown), G.N. Woodruff	67
16	Effect of the (+)-and (-)-enantiomers of sulpiride on ADTN-induced hyperactivity in the rat [proceedings]. 1978 ·PubMed Central ·Christopher Andrews, G.N. Woodruff	9
17	The actions of cholinomimetics and catecholamines on rat substantia nigra neurones [proceedings]. 1977 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Julie Ann Kemp, Robert Walker, G.N. Woodruff	3
18	Proceedings: The effect of dopamine receptor stimulants on locomotor activity and cyclic AMP levels in the rat striatum. 1975 ·British Journal of Pharmacology ·A.O. Elkhawad, K. A. Munday, Judith A. Poat, G.N. Woodruff	4
19	PROCEEDINGS OF THE BRITISH PHARMACOLOGICAL SOCIETY 1971 ·British Journal of Pharmacology ·Robert Walker, G.N. Woodruff, A. W. Cuthbert, P.Y.D. Wong, Sónia Ferreira, Salvador Moncada, Ryszard J. Gryglewski, John R. Vane, James McCormick, J. Senior, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	6
20	THE EFFECTS OF HISTAMINE AND OTHER NATURALLY OCCURRING IMIDAZOLES ON NEURONES OF HELIX ASPERSA 1968 ·British Journal of Pharmacology and Chemotherapy ·G.A. Kerkut, Robert Walker, G.N. Woodruff	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact